Los Angeles Biotechnology Network
Advertise With Biotech Networks
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ October 3, 2023 ] City of Hope Opens First U.S. Multicenter Clinical Trial for Robotic Single-Port Mastectomies for Breast Cancer Patients Los Angeles Biotech News
  • [ October 3, 2023 ] Sr Biostatistician – Glaukos Corporation – Aliso Viejo, CA Los Angeles Biotech Jobs
  • [ October 3, 2023 ] Leaniar LLC Attains UiPath Platinum Partner Status, Pioneering Automation in Healthcare, Manufacturing, Supply Chain, and E-Commerce Los Angeles Biotech News
  • [ October 3, 2023 ] Serimmune Announces Use of Its SERA Platform in Study Designed to Identify Features of Long COVID Through Immune Profiling Los Angeles Biotech News
  • [ October 3, 2023 ] ImmPACT Bio to Present at Cell & Gene Meeting on the Mesa Los Angeles Biotech News
HomeLos Angeles Biotech NewsAmgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition

Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition

September 1, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition

THOUSAND OAKS, Calif., & DUBLIN–(BUSINESS WIRE)–AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
Click here to view original post

Previous

David Khougazian joins Flagship to build ‘partnerships with different flavors’; Former Novo Nordisk exec to lead Evaxion

Next

Who Will You Save This Childhood Cancer Awareness Month

Follow/Subscribe

Advertise With Biotech Networks
POST A JOB
Tweets by LABioNetwork
Advertise With Biotech Networks

Copyright © 2023 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered